Dietmar Berger

M.D., Ph.D. Chief Medical OfficeratGilead Sciences· In the 2025 proxy

Pay in FY2025Gilead Sciences stock +32.9% the same year

Dietmar Berger was paid $13.9M in FY2025 (Dec). Gilead Sciences stock rose 32.9% that year.

Pay$100 in the stock at the end of FY24 → $133

Pay is from the Summary Compensation Table of each Gilead Sciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

GILD
Gilead SciencesPublic company · 1 yr
- M.D., Ph.D. Chief Medical Officer2025 – Present · 1 yrStock in role +69%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?